A director at Lonza Group AG bought/sold 239 shares at 506.800CHF and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Danone: Information on the total number of voting rights and shares DANONE French Société anonyme with a capital of €170,348,620.75.Registered Office: 59-61, rue La Fayette, 75009 Paris.Registered with the Paris Commerce and Company Registry under number 552 032 534 Information on the total number of voting rights and shares in compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers) DateTotal number of sharesTotal number of voting rights28/02/2026681,394...
DANONE : Informations relatives au nombre total de droits de vote et d’actions DANONE Société anonyme à Conseil d’Administration au capital de 170 348 620,75 €.Siège social : 59-61, rue La Fayette, 75 009 Paris.552 032 534 R.C.S. Paris. Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du code de commerce et l’article 223-16 du règlement général de l’Autorité des marchés financiers DateNombre d’actionsNombre total de droits de vote28/02/2026681 394 483Nombre de droits de vote théoriques (1) : 721 342 940Nombre de droit de votes exerç...
Transactions in Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; March 9, 2026 – Genmab A/S (Nasdaq: GMAB). On February 17, 2026, Genmab announced the initiation of a share buy-back program to repurchase up to 342,130 shares with a maximum aggregate total value of DKK 725 million to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than March 31, 2026. The following transactions were executed under the program from March 2 to March 6, 2026: No. of sharesAverage price (DKK)Tot...
Our Big Pharma AI thesis is the result of ~25 interviews with industry execs & >100hrs of research. We show ~10% of OPEX could be saved by AI within a few years & conclude the recent sector rally is wholly justified & could run further. We assess the winners & losers from AI adoption and discuss in detail some of the short, mid & long-term consequences. We evaluate the various AI use cases and quantify the potential benefit they may have. We break down SG&A & R&D activities & show where AI is im...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.